Globus Medical, Inc. (GMED)

NYSE: GMED · IEX Real-Time Price · USD
53.64
+0.58 (1.09%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.

It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents.

Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Globus Medical, Inc.
Globus Medical logo
Country United States
Founded 2003
IPO Date Aug 3, 2012
Industry Medical Devices
Sector Healthcare
Employees 5,000
CEO Daniel T. Scavilla

Contact Details

Address:
2560 General Armistead Avenue
Audubon, Pennsylvania 19403
United States
Phone 610-930-1800
Website globusmedical.com

Stock Details

Ticker Symbol GMED
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001237831
CUSIP Number 379577208
ISIN Number US3795772082
Employer ID 04-3744954
SIC Code 3841

Key Executives

Name Position
David C. Paul Co-Founder and Executive Chairman
Daniel T. Scavilla President, Chief Executive Officer and Director
Keith W. Pfeil Chief Financial Officer and Chief Operating Officer
Kelly G. Huller Esq. Senior Vice President, General Counsel and Secretary
Brian J. Kearns Senior Vice President of Business Development and Investor Relations

Latest SEC Filings

Date Type Title
Mar 15, 2024 144 Filing
Mar 1, 2024 144 Filing
Feb 21, 2024 10-K Annual Report
Feb 20, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 5, 2024 8-K Current Report
Jan 24, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals